• Entity registrant name: ULTRAPAR HOLDINGS INC (CIK: 0001094972)
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1094972/000119312518152913/0001193125-18-152913-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1094972/000119312518152913/ugp-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • XBRL Cloud Rendering (requires license): Click to open XBRL Cloud Component Rendering
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001094972
  • Open this page in separate window: Click
  • * * *

    Component: (Network and Table)
    Network
    00000006 - Statement - Statements of Cash Flows—Indirect Method
    (http://ultra.com.br/role/StatementsOfCashFlowsindirectMethod)
    Table (Implied)
    Slicers (applies to each fact value in each table cell)
    Statement of cash flows [abstract] Period [Axis]
    2017-01-01 - 2017-12-31
    2016-01-01 - 2016-12-31
    2015-01-01 - 2015-12-31
    Statement of cash flows [abstract]
     
     
     
    Cash flows from operating activities
     
     
     
    Net income for the year
    1,573,868,000  
    1,570,618,000  
    1,512,972,000  
    Adjustments to reconcile net income to cash provided by operating activities
     
     
     
    Share of loss (profit) of joint ventures and associates
    (20,673,000) 
    (7,476,000) 
    10,884,000  
    Depreciation and amortization
    1,175,951,000  
    1,103,538,000  
    1,002,647,000  
    PIS and COFINS credits on depreciation
    13,134,000  
    12,581,000  
    12,146,000  
    Asset retirement obligation
    (15,432,000) 
    (2,785,000) 
    (3,949,000) 
    Interest, monetary, and foreign exchange rate variations
    854,671,000  
    763,793,000  
    1,582,579,000  
    Deferred income and social contribution taxes
    (83,029,000) 
    (100,505,000) 
    14,813,000  
    (Gain) loss on disposal of property, plant and equipment and intangibles
    2,242,000  
    6,134,000  
    (27,276,000) 
    Others
    (868,000) 
    (6,515,000) 
    13,313,000  
    Adjustments, total
    3,499,864,000  
    3,339,383,000  
    4,118,129,000  
    (Increase) decrease in current assets
     
     
     
    Trade receivables
    (665,145,000) 
    (326,695,000) 
    (615,381,000) 
    Inventories
    (605,757,000) 
    (262,993,000) 
    (615,390,000) 
    Recoverable taxes
    (334,217,000) 
    87,006,000  
    (60,141,000) 
    Dividends received from joint-ventures and associates
    29,411,000  
    7,925,000  
    3,417,000  
    Insurance and other receivables
    358,682,000  
    (309,725,000) 
    13,555,000  
    Prepaid expenses
    (23,016,000) 
    (39,980,000) 
    (14,209,000) 
    Increase (decrease) in current liabilities
     
     
     
    Trade payables
    412,393,000  
    249,121,000  
    181,030,000  
    Salaries and related charges
    7,149,000  
    (41,595,000) 
    109,734,000  
    Taxes payable
    34,707,000  
    2,229,000  
    29,969,000  
    Income and social contribution taxes
    783,663,000  
    567,286,000  
    504,495,000  
    Post-employment benefits
    5,119,000  
    11,193,000  
    0  
    Provision for tax, civil, and labor risks
    11,857,000  
    7,372,000  
    (18,847,000) 
    Insurance and other payables
    (33,955,000) 
    56,811,000  
    29,235,000  
    Deferred revenue
    (3,887,000) 
    (2,120,000) 
    970,000  
    (Increase) decrease in non-current assets
     
     
     
    Trade receivables
    (102,905,000) 
    (74,846,000) 
    (8,433,000) 
    Recoverable taxes
    (130,200,000) 
    (47,168,000) 
    (60,045,000) 
    Escrow deposits
    (39,795,000) 
    (37,935,000) 
    (44,000,000) 
    Other receivables
    (4,356,000) 
    13,829,000  
    (10,675,000) 
    Prepaid expenses
    (116,735,000) 
    (65,847,000) 
    (15,437,000) 
    Increase (decrease) in non-current liabilities
     
     
     
    Post-employment benefits
    13,209,000  
    (40,000) 
    10,868,000  
    Provision for tax, civil, and labor risks
    (68,193,000) 
    42,428,000  
    61,388,000  
    Other payables
    87,950,000  
    (19,255,000) 
    20,130,000  
    Deferred revenue
    385,000  
    1,474,000  
    3,327,000  
    Income and social contribution taxes paid
    (836,808,000) 
    (644,188,000) 
    (422,010,000) 
    Net cash provided by operating activities
    2,279,420,000  
    2,513,670,000  
    3,201,679,000  
    Cash flows from investing activities
     
     
     
    Financial investments, net of redemptions
    60,859,000  
    (163,625,000) 
    573,446,000  
    Acquisition of subsidiary, net of cash acquired
    59,863,000  
    0  
    0  
    Acquisition of property, plant, and equipment
    (1,262,558,000) 
    (1,015,199,000) 
    (803,503,000) 
    Acquisition of intangible assets
    (801,971,000) 
    (651,171,000) 
    (609,600,000) 
    Capital increase in joint ventures
    (16,000,000) 
    (47,281,000) 
    (41,080,000) 
    Proceeds from disposal of property, plant and equipment and intangibles
    47,670,000  
    28,500,000  
    78,941,000  
    Net cash used in investing activities
    (1,912,137,000) 
     
    (1,848,776,000) 
     
    (801,796,000) 
     
    Cash flows from financing activities
     
     
     
    Loans and debentures
         
    Proceeds
    4,510,694,000  
    3,676,874,000  
    2,384,589,000  
    Repayments
    (2,462,200,000) 
    (812,520,000) 
    (2,824,543,000) 
    Interest paid
    (769,740,000) 
    (1,057,580,000) 
    (855,190,000) 
    Payments of financial lease
    (5,191,000) 
    (5,016,000) 
    (5,174,000) 
    Dividends paid
    (940,250,000) 
    (873,270,000) 
    (831,654,000) 
    Acquisition of non-controlling interests of subsidiaries
    0  
    0  
    (9,000) 
    Acquisition of own shares to be held in treasury
    0  
    0  
    (388,718,000) 
    Related parties
    7,036,000  
    (100,000) 
    0  
    Net cash provided by (used in) financing activities
    340,349,000  
     
    928,388,000  
     
    (2,520,699,000) 
     
    Effect of exchange rate changes on cash and cash equivalents in foreign currency
    20,214,000  
    (22,017,000) 
    (3,660,000) 
    Increase (decrease) in cash and cash equivalents
    727,846,000  
    1,571,265,000  
    (124,476,000) 
    Cash and cash equivalents at the beginning of the year
    4,274,158,000  
    2,702,893,000  
    2,827,369,000  
    Cash and cash equivalents at the end of the year
    5,002,004,000  
     
    4,274,158,000  
     
    2,702,893,000  
     
    Additional information—transactions that do not affect cash and cash equivalents:
     
     
     
    Extrafarma acquisition – capital increase and subscription warrants
         
    Extrafarma acquisition – gross debt assumed on the closing date